Superworth

Bausch & Lomb price to free cash flow BLCO

Market value divided by free cash flow over the last twelve months, since 2023.

Today, Nov 2, 2026
52.2×
4-year median
45.0×
Against its 4-year history
63rd
percentile: 0 is its lowest day, 100 its highest
4-year range
32.7× to 63.0×
Peer median
19.5×

Bausch & Lomb's price to free cash flow is 52.2× as of Nov 2, 2026.

That is above its 4-year median of 45.0×, close to the middle of its last 4 years.

Over that time it ranged from 32.7× in Mar 2023 to 63.0× in Jul 2023.

The median for 10 medical instruments and supplies stocks of a similar size is 19.5×.

Price to free cash flow over time

Open the interactive chart, with overlays and comparisons

Year by year

YearEnd of yearLowHigh
2026 so far52.2×43.0×52.2×
2025n/m a value too high to mean anything
2024n/m a value too high to mean anything
202359.6×32.7×63.0×

Against its peers

Companies in Medical - Instruments & Supplies nearest Bausch & Lomb's size, closest first, today.

CompanyPrice to free cash flow
BLCOBausch & Lomb52.2×
MSAMSA Safety20.3×
HAEHaemonetics18.8×
MMSIMerit Medical Systems24.8×
VNTVontier12.9×
PODDInsulet36.3×
GMEDGlobus Medical14.1×
ALGNAlign Technology17.3×
BMIBadger Meter31.6×
COOCooper Companies17.2×
ICUIICU Medical26.6×
Peer median19.5×

What the price to free cash flow tells you

Market value divided by free cash flow: the cash left after running the business and paying for equipment. Cash is harder to manage than accounting earnings, so many investors trust this more than PE.

Lumpy: a big year of building factories drops cash flow and inflates the ratio without the business getting worse.

More on Bausch & Lomb

Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.